Kravitz goes further, concluding, “Findings like these suggest that [direct-to-consumer advertising] of prescription drugs as currently regulated in the United States is unlikely to yield consistent public health gains.” Currently, the US and New Zealand are the only two developed countries that allow such drug advertisements.